US Broker Ratings

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Exploring the 32% Upside Potential

Thermo Fisher Scientific Inc (NYSE: TMO), a titan in the healthcare sector, primarily operating within the diagnostics and research industry, has been a cornerstone for investors seeking stability and growth..

Agilent Technologies (A) Stock Analysis: Unpacking a 34.86% Potential Upside for Investors

Agilent Technologies, Inc. (NYSE: A), a stalwart in the healthcare sector and a key player within the diagnostics and research industry, has captured investor attention with its substantial 34.86% potential..

Elanco Animal Health (ELAN) Stock Analysis: Evaluating Growth Potential in the Animal Healthcare Sector

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a prominent player in the healthcare sector, specifically within the niche of animal health. With its roots dating back to 1954, the..

Gilead Sciences, Inc. (GILD): Investor Outlook on Robust Growth and Strategic Collaborations

Gilead Sciences, Inc. (NASDAQ: GILD), a stalwart in the healthcare sector, continues to capture investor attention with its formidable market presence and strategic collaborations that underpin its growth potential. As..

McKesson Corporation (MCK) Stock Analysis: Navigating the Healthcare Sector with Strong Buy Ratings and Growth Potential

McKesson Corporation (NYSE: MCK) stands as a formidable player in the healthcare industry, particularly as a leading force in medical distribution. With a market capitalization of $115.37 billion, McKesson’s extensive..

Becton, Dickinson and Company (BDX) Stock Analysis: Exploring the 11.08% Potential Upside for Investors

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, continues to capture investor interest with its robust portfolio of medical instruments and diagnostic products. With a market..

Charles River Laboratories (CRL) Stock Analysis: Unpacking a Potential 33.71% Upside

Charles River Laboratories International, Inc. (NYSE: CRL), a key player in the healthcare sector specializing in diagnostics and research, presents an intriguing opportunity for investors with its significant potential upside...

BeOne Medicines Ltd. (ONC) Stock Analysis: Unveiling a 18.24% Potential Upside in the Biotech Arena

BeOne Medicines Ltd. (ONC), a key player in the biotechnology space, is capturing the attention of investors with its promising portfolio and robust growth metrics. Based in Basel, Switzerland, the..

IQVIA Holdings, Inc. (IQV)

⚠️ No article content returned.

..

Bruker Corporation (BRKR) Stock Analysis: Exploring a 32.64% Upside Potential Amidst Market Challenges

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, specifically within the medical devices industry, offers a compelling case for investors seeking opportunities amidst the current market turbulence...

Encompass Health Corporation (EHC) Stock Analysis: A Robust 29.59% Upside Potential Ignites Investor Interest

Encompass Health Corporation (NYSE: EHC) stands out in the healthcare sector, specifically within the medical care facilities industry, due to its substantial market presence and promising growth prospects. With a..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: A Closer Look at Its 3.58% Dividend Yield and Growth Potential

For investors seeking exposure in the healthcare sector, Takeda Pharmaceutical Company Limited (NYSE: TAK) presents a compelling opportunity. As a prominent player in the drug manufacturing industry, specializing in both..

Qiagen N.V. (QGEN) Stock Analysis: Navigating the Diagnostics & Research Landscape with an 8.90% Potential Upside

Qiagen N.V. (QGEN), a prominent player in the diagnostics and research sector, continues to capture investor attention with its robust market presence and innovative solutions. Based in Venlo, the Netherlands,..

Mettler-Toledo International (MTD) Stock Analysis: 10% Upside Potential in the Diagnostics & Research Sector

Mettler-Toledo International Inc. (NYSE: MTD), a prominent player in the diagnostics and research industry, is capturing investor attention with its robust market presence and promising growth potential. Headquartered in Greifensee,..

Humana Inc. (HUM) Stock Analysis: Navigating a 25% Potential Upside in the Healthcare Sector

Humana Inc. (NYSE: HUM), a prominent player in the healthcare sector, presents a compelling opportunity for investors seeking growth and stability in a rapidly evolving industry. With its headquarters in..

Insmed Incorporated (INSM) Stock Analysis: An In-Depth Look at Its 44% Potential Upside

Investors eyeing the biotechnology sector may want to give Insmed Incorporated (NASDAQ: INSM) a closer look. With its focus on developing and commercializing therapies for serious and rare diseases, Insmed..

Alcon Inc. (ALC) Stock Analysis: Evaluating Growth Potential with a 15.91% Upside

Alcon Inc. (NYSE: ALC), a leading global player in the healthcare sector, particularly in Medical Instruments & Supplies, presents an intriguing prospect for investors looking to tap into the ophthalmic..

Edwards Lifesciences (EW) Stock Analysis: 27% Potential Upside Captures Investor Attention

Edwards Lifesciences Corporation (EW), a stalwart in the healthcare sector, operates within the medical devices industry. With a market capitalization of $44.54 billion, this California-based company is a key player..

Moderna, Inc. (MRNA) Stock Analysis: Navigating a Challenging Landscape with Strategic Collaborations

As a prominent player in the biotechnology sector, Moderna, Inc. (NASDAQ: MRNA) has captured significant investor attention, particularly due to its groundbreaking mRNA technology and its pivotal role in COVID-19..

Doximity, Inc. (DOCS) Stock Analysis: Exploring a 60% Upside Potential in the Healthcare Information Sector

Doximity, Inc. (NYSE: DOCS), a prominent player in the healthcare information services industry, offers a digital platform tailored for medical professionals in the United States. With a market capitalization of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds